Nenolizumab has recently been approved for two chronic skin conditions
image: ©nensuria | iStock A new medicine, Nenolizumab, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA)...
image: ©nensuria | iStock A new medicine, Nenolizumab, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA)...
Contact Dermatitis Market Outlook 2025-2035:The 7 major contact dermatitis market reached a value of USD 11.4 Billion in 2024. Looking...
Despite its name, ringworm isn’t an infection caused by worms or a parasite. Rather, it’s an infection caused by fungi...
Speaking at Hospital Healthcare Europe’s Clinical Excellence in Respiratory Care event, our panel of three respiratory experts considered the use...
The European Child Guarantee, the first EU-level policy addressing childhood challenges and exclusion, has a new monitoring framework....
According to expert understanding dermatomyositis skin issues also aids in preventing long-term complications by informing patients about lifestyle modifications...
Amrita Hospital, Kochi on Wednesday inaugurated two specialised clinics, a dedicated Sarcoidosis Clinic and the new Interstitial Lung Disease Clinic....
Kochi/ JAN 11, 2024: The first-ever dedicated sarcoidosis clinic and the ILD (interstitial lung disease) clinic were opened by Amrita...
As the winter season approaches, the National Health Service (NHS) prepares for an increase in the number of patients infected...